Profiel
Stephen M.
Rodin currently works at Annovation BioPharma, Inc., as Secretary & Director, The Medicines Co., as Executive Vice President & General Counsel, and Whitehawk Therapeutics, Inc., as Secretary, Senior VP & General Counsel from 2022.
Mr. Rodin also formerly worked at Proskauer Rose LLP, as Associate from 2002 to 2007.
Mr. Rodin received his undergraduate degree in 1997 from Georgetown University and graduate degree in 2002 from Vanderbilt Law School.
Actieve functies van Stephen M. Rodin
| Bedrijven | Functie | Begin |
|---|---|---|
| THE MEDICINES COMPANY | Algemeen Adviseur | - |
| WHITEHAWK THERAPEUTICS, INC. | Algemeen Adviseur | 01-02-2022 |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Directeur/Bestuurslid | - |
Eerdere bekende functies van Stephen M. Rodin
| Bedrijven | Functie | Einde |
|---|---|---|
Proskauer Rose LLP
Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01-10-2007 |
Opleiding van Stephen M. Rodin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Develops pharmaceutical products in the field of anesthesia, sedation and sleep | |
Proskauer Rose LLP
Proskauer Rose LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vanderbilt Law School
Vanderbilt Law School Functions as a College/University | |
Aadi Bioscience, Inc.
Aadi Bioscience, Inc. Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases |
















